What is the role of hydrocortisone injection in the treatment of anaphylactic shock?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hydrocortisone in Anaphylactic Shock: Secondary Adjunct Only

Hydrocortisone 200 mg IV is a secondary adjunctive therapy in anaphylactic shock that should only be administered AFTER epinephrine and initial stabilization—it has no role in acute symptom reversal and should never delay or replace epinephrine administration. 1

Primary Treatment Algorithm

Epinephrine is the only first-line treatment for anaphylactic shock and must be given immediately: 1, 2

  • Intramuscular route preferred initially: 0.3-0.5 mg (0.5 mL of 1:1000 solution) into the anterolateral thigh for adults 1
  • IV epinephrine for shock: 0.05-0.1 mg IV bolus (5-10% of cardiac arrest dose) when IV access already established, or continuous infusion at 5-15 μg/min for refractory hypotension 1
  • Aggressive fluid resuscitation: Large volumes of normal saline or lactated Ringer's solution via large-bore IV 1

Why Hydrocortisone Has Limited Acute Value

The mechanism of glucocorticoids explains their ineffectiveness in acute anaphylaxis: 1, 2

  • Onset of action is 4-6 hours minimum because they work by binding to glucocorticoid receptors, translocating to the nucleus, and inhibiting gene expression—this cannot reverse acute cardiovascular collapse or bronchospasm 1, 2
  • No evidence for preventing biphasic reactions: Despite widespread use, glucocorticoids are not reliable interventions to prevent biphasic anaphylaxis 2
  • Lack critical pharmacologic effects: Unlike epinephrine, they have no vasoconstrictive, bronchodilatory, ionotropic, or immediate mast cell stabilization properties 1

When to Consider Hydrocortisone

Administer hydrocortisone 200 mg IV only as secondary management after epinephrine and stabilization in these specific scenarios: 1, 2

  • Patients with underlying asthma or those recently treated with corticosteroids 1
  • Severe or prolonged anaphylaxis requiring multiple epinephrine doses 2
  • History of idiopathic anaphylaxis 2
  • After initial resuscitation is underway—never delay epinephrine to give hydrocortisone 1

Alternative dosing: Oral prednisone 0.5 mg/kg may be sufficient for milder reactions 1

Critical Pitfalls to Avoid

Never use hydrocortisone as first-line therapy or in place of epinephrine—this dangerous practice contributes to anaphylaxis fatalities: 2, 3, 4

  • Delay in epinephrine administration is directly associated with increased mortality and biphasic reactions 2, 3
  • Glucocorticoids cannot address acute cardiovascular collapse or respiratory distress 1, 2
  • Even mild initial symptoms can rapidly progress to fatal reactions, making immediate epinephrine critical regardless of apparent severity 3

Complete Secondary Management Protocol

After epinephrine and fluid resuscitation, consider these adjuncts in order: 1

  1. Chlorphenamine (H1 antihistamine): 10 mg IV for adults—addresses only cutaneous symptoms (urticaria, itching) with slow onset 1
  2. Hydrocortisone: 200 mg IV for adults 1
  3. Alternative vasopressors: If hypotension persists despite epinephrine infusion, consider metaraminol or other vasopressors 1
  4. Bronchodilators: IV salbutamol infusion or inhaled beta-2 agonists for persistent bronchospasm refractory to epinephrine 1

Monitoring Requirements

Patients in anaphylactic shock require: 1

  • Close cardiovascular and respiratory monitoring as status can change rapidly 1
  • Mast cell tryptase levels at initial presentation, 1-2 hours, and 24 hours for diagnostic confirmation 1
  • Transfer to critical care area for severe cases 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Anaphylaxis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Customizing anaphylaxis guidelines for emergency medicine.

The Journal of emergency medicine, 2013

Research

Anaphylaxis: Emergency Department Treatment.

Emergency medicine clinics of North America, 2022

Related Questions

What is the first aid treatment for anaphylactic shock?
What are the most critical errors physicians can make when treating anaphylactic shock?
What medication is given to treat anaphylaxis with symptoms of itching, skin erythema, tongue edema, and hypotension?
What is the immediate course of action for a patient who develops shock, anaphylaxis, or another serious reaction after receiving an intravenous (IV) antibiotic in an outpatient setting?
What is the treatment for anaphylactic shock?
Is Duolin (ipratropium bromide and salbutamol) safe to use in a patient with paroxysmal supraventricular tachycardia (PSVT) and co-existing chronic obstructive pulmonary disease (COPD) or asthma?
What is the recommended treatment for a pediatric patient with 3 days of diarrhea and vomiting?
What is the recommended dose and duration of erythromycin (macrolide antibiotic) for a young adult patient with pityriasis rosea?
What are the considerations for using Duolin (ipratropium bromide and salbutamol) in a patient with paroxysmal supraventricular tachycardia (PSVT) and elevated troponin (trop T) levels, who also has chronic obstructive pulmonary disease (COPD) or asthma?
What is the recommended dose and duration of Acyclovir for a young adult patient with pityriasis rosea and no significant medical history or allergies?
What is the most appropriate antihistamine for a patient with allergies, considering options such as fexofenadine (Allegra), loratadine (Claritin), cetirizine (Zyrtec), and levocetirizine (Xyzal)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.